Enhancements    

TARGETING A STRESS-DERIVED IMMUNOSUPPRESSIVE ADENOSINE PATHWAY IN TUMORS RESISTANT TO CHECKPOINT INHIBITORS

TARGETING A STRESS-DERIVED IMMUNOSUPPRESSIVE ADENOSINE PATHWAY IN TUMORS RESISTANT TO CHECKPOINT INHIBITORS
PI: Yong Qin
Sponsor: US ARMY MEDICAL RESEARCH AND DEVELOPMENT COMMAND
Pharmacy
Amount awarded: $573,908

This project investigates immunotherapies in resistant cancers, such as pancreatic cancer.

Posting date: Mon, 11/09/2020

Award start date: Sun, 11/01/2020
Award end date: Mon, 10/31/2022